Weekly Events Preview — August 17–August 21, 2026

Calendar At-a-Glance

Monday, August 17

Before Open: H World Group (HTHT), NRx Pharmaceuticals (NRXP), TOYO Co. (TOYO) After Close: POET Technologies (POET), Gossamer Bio (GOSS), Fabrinet (FN), 4D Molecular Therapeutics (FDMT), Flexsteel Industries (FLXS) Events: None

Tuesday, August 18

Before Open: Baidu (BIDU), Home Depot (HD), Klarna Group (KLAR), Amer Sports (AS), Prenetics Global (PRE), Vera Therapeutics (VERA) After Close: Auna S.A. (AUNA), Gold Resource Corp (GORO) Events: None

Wednesday, August 19

Before Open: Analog Devices (ADI), Target (TGT), Lowe’s (LOW), TJX Companies (TJX), Dycom Industries (DY), Estée Lauder (EL), ZIM Integrated Shipping (ZIM) After Close: BILL Holdings (BILL) Events: None

Thursday, August 20

Before Open: Walmart (WMT), Alibaba (BABA), Advance Auto Parts (AAP), Autohome (ATHM) After Close: HIVE Digital Technologies (HIVE), Ross Stores (ROST), Nu Holdings (NU), CAMP4 Therapeutics (CAMP) Events: None

Friday, August 21

Before Open: BJ’s Wholesale Club (BJ), Ubiquiti (UI), Sol-Gel Technologies (SLGL), Amerityre Corp (AMTY), Buckle Inc (BKE), Blue Buffalo Pet Products (BUFF), Bavarian Nordic (BVNRY), Decoy Therapeutics (DCOY) Events: None

⚠️ Note: All major economic events for this preview week (CPI, PPI, Retail Sales, UoM Sentiment) fell in the prior week of August 12–14. See Economic Calendar section for how those prints set the table for this week’s trading.

Earnings to Watch

📅 Monday, August 17

POET — POET Technologies Inc. | Reports: Monday, August 17 (After Close) Consensus: EPS -$0.08, Revenue ~$0 Action: AVOID — Too speculative ahead of the print; no revenue base to anchor a bullish thesis. Claude’s take: POET is a pre-revenue photonics semiconductor startup developing its Optical Interposer platform, and the retail anticipation score of 6 is entirely narrative-driven — this is a Reddit/X-fueled AI-optical-chip story, not a fundamental one. The market is essentially watching for any partnership announcement, design win, or prototype update that could justify the stock’s run. A swing trader should resist the urge to front-run — any “beat” on the loss number is meaningless without a commercial catalyst, and if none comes, the post-earnings flush can be violent. Wait for the call transcript; if a named hyperscaler partnership drops, that’s your entry trigger the following session, not before.

GOSS — Gossamer Bio, Inc. | Reports: Monday, August 17 (After Close) Consensus: EPS -$0.10, Revenue ~$0 Action: AVOID — Clinical-stage biotech with binary catalyst risk; not a swing trade setup. Claude’s take: Gossamer Bio is a small-cap clinical-stage biotech whose story depends entirely on pipeline milestones rather than earnings beats — a -$0.10 EPS print is effectively noise. The retail anticipation (score 5) likely reflects speculative positioning around a potential data readout or pipeline update accompanying the release. Without a specific known catalyst, this is a coin flip. Biotech binary trades are for options specialists, not swing traders — the risk/reward is too asymmetric and illiquid to manage a disciplined stop.

HTHT — H World Group Limited | Reports: Monday, August 17 (Before Open) Consensus: EPS $0.65, Revenue $0.98B Action: BUY (cautiously, post-print confirmation) — China hospitality recovery play with room for upside if travel data impresses. Claude’s take: H World is China’s largest hotel chain operator, a direct beneficiary of domestic travel recovery and the broader reopening consumer narrative in mainland China. With consensus at $0.98B in revenue, the bar is modest — Chinese hotel operators have been steadily rebuilding occupancy rates and average daily rates, and if HTHT’s RevPAR data for Q2 shows continued year-over-year improvement, a gap-up is plausible. The key risk is macro: any renewed signs of Chinese consumer softness or regulatory noise around ADRs could cap gains. Swing traders should watch the pre-market tape — if HTHT opens up on the print, buying the first 30-minute pullback toward the breakout level is the cleaner entry than chasing the open.

NRXP — NRx Pharmaceuticals, Inc. | Reports: Monday, August 17 (Before Open) Consensus: EPS -$0.09, Revenue ~$0 Action: AVOID — Micro-cap pharma with no revenue; this is a press release trade, not an earnings trade. Claude’s take: NRx is a development-stage pharmaceutical company with anticipation driven entirely by retail speculation around its pipeline (historically centered on NRX-101 for bipolar depression and Zyesami for critical care). An EPS of -$0.09 on zero revenue tells you everything — there is nothing to analyze fundamentally. The score of 3 suggests some retail positioning, but swing traders have no edge here. If a meaningful FDA or partnership announcement accompanies the release, the move will be too fast to trade responsibly without pre-positioning, which itself carries binary risk.

TOYO — TOYO Co., Ltd | Reports: Monday, August 17 (Before Open) Consensus: EPS $0.52, Revenue $0.19B Action: AVOID — Limited US market data and thin liquidity make this unsuitable for most swing setups. Claude’s take: TOYO is a Japanese-listed company with a US ADR presence, and the thin revenue estimate of $0.19B with a $0.52 EPS figure suggests a niche industrial or specialty business. The anticipation score of 2 is low, and US swing traders have minimal informational edge on a Japanese company reporting in this time slot. Spreads will be wide, volume unpredictable, and any reaction is likely muted unless there’s a major surprise. Pass.

FDMT — 4D Molecular Therapeutics, Inc. | Reports: Monday, August 17 (After Close) Consensus: EPS -$1.04, Revenue ~$0 Action: AVOID — Deep-burn clinical-stage gene therapy; earnings are irrelevant, pipeline is everything. Claude’s take: FDMT is a gene therapy company working on targeted genetic medicines with its Therapeutic Vector Evolution platform. The -$1.04 EPS consensus reflects heavy R&D burn with no commercial product yet on market. Retail interest (score 2) is minimal, and rightly so from an earnings-trade perspective — the only thing that moves this stock meaningfully is clinical data updates or partnership news that could accompany the call. Gene therapy as a subsector has been volatile in 2025-2026 following mixed Phase 2/3 readouts across the space. Unless you’re tracking a specific trial catalyst here, this is not a swing trade.

FLXS — Flexsteel Industries, Inc. | Reports: Monday, August 17 (After Close) Consensus: EPS $1.15, Revenue $0.11B Action: BUY (if housing/furniture data has been constructive) — Small-cap furniture maker with potential as a tariff-relief beneficiary. Claude’s take: Flexsteel is a US-based upholstered furniture manufacturer serving both residential and commercial markets. The $1.15 EPS estimate on $0.11B revenue suggests the bar is already reasonably set — and with the housing market showing some spring 2026 stabilization following the 2024-2025 rate cycle, discretionary furniture spending may be quietly recovering. The critical swing-trade angle here is tariffs: Flexsteel sources some materials internationally, and any commentary on improved supply chain costs or US manufacturing tailwinds could be a catalyst. Anticipation score of 2 means expectations are low — low expectations plus a modest beat is often the best setup. This is a small-cap illiquid name, so size accordingly and use limit orders.

FN — Fabrinet | Reports: Monday, August 17 (After Close) Consensus: EPS $3.69, Revenue $1.28B Action: BUY (pre-earnings positioning justified) — AI infrastructure optical networking play with strong secular tailwinds; but priced for a beat so size wisely. Claude’s take: Fabrinet is one of the most important “picks and shovels” names in the AI/optical networking buildout — it manufactures complex optical, electro-optical, and electro-mechanical products for companies like Coherent, Ciena, and critically, next-gen AI data center connectivity providers. The $1.28B revenue estimate is meaningful, and the trend here has been beat-and-raise for several consecutive quarters as hyperscaler capex remains aggressive. The risk is that FN has likely run up into this print — if the stock has had a strong run in recent weeks, the bar for a positive reaction is elevated, and guidance is everything. A swing trader should watch whether FN’s print confirms the broader optical/AI networking theme that also sets up the Analog Devices report Wednesday — these two together are the clearest read-through on AI infrastructure demand this week.

📅 Tuesday, August 18

BIDU — Baidu, Inc. | Reports: Tuesday, August 18 (Before Open) Consensus: EPS $1.19, Revenue $4.65B Action: BUY (with tight stop) — AI monetization story with a low valuation bar; beat likely if Ernie Bot traction continues. Claude’s take: Baidu is China’s dominant search and AI company, and $4.65B in revenue consensus reflects a modest expectation set against a backdrop of ongoing Chinese tech volatility. The real story is Ernie Bot — Baidu’s generative AI platform — and any meaningful data on paid API calls, enterprise adoption, or AI cloud revenue acceleration could send shares sharply higher. The anticipation score of 6 reflects retail interest in the China AI theme, which has been volatile but rewarding on dip plays. Baidu ADRs trade at a steep discount to US AI peers, so the asymmetry is favorable if the numbers show even modest Ernie Bot monetization traction. Key risk: macro China sentiment and any surprise regulatory commentary.

HD — Home Depot, Inc. | Reports: Tuesday, August 18 (Before Open) Consensus: EPS $4.71, Revenue $47.5B Action: BUY (post-print on beat/raise) — The bellwether of the US housing and home improvement cycle; catalytic for the entire sector. Claude’s take: Home Depot is the single most important retail earnings report of the week outside of Walmart — at $47.5B in estimated revenue, it’s a macro proxy for US housing activity, contractor spending, and big-ticket consumer durables. The setup is interesting: mortgage rates have moderated somewhat from their 2024 peaks, and if HD management signals any improvement in Pro (contractor) demand or weather-related recovery projects, the stock could make a significant move. HD has been range-bound while the market awaited evidence that the housing remodel cycle is recovering — a beat-and-raise here breaks that range and carries implications for LOW, which reports Wednesday. The risk is if same-store sales remain negative year-over-year — any further signs of the “housing lock-in” effect (homeowners staying put rather than moving and renovating) weighs on the thesis.

KLAR — Klarna Group plc | Reports: Tuesday, August 18 (Before Open) Consensus: EPS -$0.07, Revenue $0.99B Action: BUY (aggressive, higher risk) — One of 2026’s most closely watched fintech IPOs reporting early results as a public company. Claude’s take: Klarna is the Swedish BNPL (Buy Now Pay Later) fintech giant that recently went public, and this early print as a public company will set the tone for investor perception of its business model durability. At ~$0.99B in revenue with a near-breakeven EPS, Klarna is further along the profitability path than many fintech peers were at this stage. The anticipation score of 5 understates the institutional interest — every growth-fund manager will be watching credit loss rates, active user growth, and US market penetration data. If Klarna shows credit quality holding up and US GMV accelerating, the stock could trade significantly higher. The risk: any deterioration in BNPL default rates in the current consumer credit environment would be a serious red flag. This is a high-volatility post-IPO name — use a wide stop or express the trade via defined-risk options.

AS — Amer Sports, Inc. | Reports: Tuesday, August 18 (Before Open) Consensus: EPS $0.10, Revenue $1.54B Action: BUY (modest, tactical) — Premium athletic brand portfolio with Arc’teryx as the crown jewel; margins are the key number to watch. Claude’s take: Amer Sports owns Arc’teryx, Salomon, Wilson, and Peak Performance — a premium-tier sporting goods and outdoor apparel portfolio. The $1.54B revenue estimate at $0.10 EPS reflects a company still investing heavily in brand growth, particularly Arc’teryx’s global expansion. The premium outdoor/athletic segment has shown surprising resilience even as mass-market apparel wobbles — wealthy consumers keep buying $800 jackets. A swing trader should focus on Arc’teryx direct-to-consumer growth and margin trajectory; if gross margins are expanding alongside top-line growth, this is a genuine beat-and-re-rate candidate. The stock is less liquid than mega-cap peers, so position size accordingly.

PRE — Prenetics Global Limited | Reports: Tuesday, August 18 (Before Open) Consensus: EPS -$0.32, Revenue $0.05B Action: AVOID — Nano-cap with minimal revenue; this is a story stock, not an earnings trade. Claude’s take: Prenetics is a Hong Kong-based health genomics and diagnostics company that pivoted from COVID testing into preventive health and cancer screening. The $0.05B revenue estimate with a -$0.32 EPS tells you the profitability runway is long and the business is still subscale. Anticipation score of 3 likely reflects some retail interest in the DNA/genomics theme, but there’s simply not enough operational scale here to generate a meaningful earnings catalyst. Avoid.

VERA — Vera Therapeutics, Inc. | Reports: Tuesday, August 18 (Before Open) Consensus: EPS -$1.60, Revenue ~$0 Action: AVOID (unless you have a specific pipeline catalyst thesis) — Deep-loss biotech with binary data risk. Claude’s take: Vera Therapeutics is developing treatments for immune-mediated diseases, notably atacicept for IgA nephropathy (IgAN) — a space that has gotten competitive and volatile following several high-profile trial readouts. A -$1.60 EPS loss on no revenue means this is purely a pipeline/data event. The anticipation score of 2 is low, but the IgAN space (with RarlyX, Calliditas, and others) has been a hot subsector — any clinical update could swing the stock 30-50% in a session. This is not a swing trade; it’s a speculative biotech position that requires deep therapeutic area knowledge to manage properly.

AUNA — Auna S.A. | Reports: Tuesday, August 18 (After Close) Consensus: EPS $0.25, Revenue $0.35B Action: AVOID — Latin American healthcare operator; limited US trading liquidity and minimal retail awareness. Claude’s take: Auna operates healthcare facilities in Peru, Mexico, and Colombia — a compelling EM healthcare growth story but one with virtually no US swing-trader relevance given thin ADR liquidity and opaque local macro dynamics. The $0.25 EPS / $0.35B revenue bar is specific enough to analyze, but the lack of a liquid options market and tight trading volume make this untradeable for most. Pass.

GORO — Gold Resource Corporation | Reports: Tuesday, August 18 (After Close) Consensus: EPS N/A (999.00 placeholder), Revenue $0.13B Action: AVOID — The “999” EPS placeholder signals no reliable estimate; uninvestable for an earnings play. Claude’s take: Gold Resource Corporation is a small gold and silver mining company, and the “999.00” EPS figure is clearly a data placeholder indicating no credible analyst estimate exists. Revenue at $0.13B puts this firmly in micro-cap territory. Gold miners as a group have benefited from elevated gold prices in 2025-2026, but GORO specifically lacks the scale, liquidity, and analyst coverage to make this an actionable swing trade around the print. If you want gold mining exposure this week, trade a major like NEM or GDX.

📅 Wednesday, August 19

ADI — Analog Devices, Inc. | Reports: Wednesday, August 19 (Before Open) Consensus: EPS $3.33, Revenue $3.92B Action: BUY (one of the highest-conviction setups of the week) — Semiconductor bellwether with direct AI and industrial exposure; the market is watching for an industrial cycle inflection. Claude’s take: Analog Devices is tied with TGT for the highest anticipation score of the day (11), and deservedly so — ADI is the essential read-through on industrial semiconductor demand, automotive electronics, and increasingly, AI data center power management. After an inventory correction that dragged through much of 2024-2025, the question is whether ADI’s book-to-bill ratio and backlog data show a genuine recovery cycle beginning. The $3.92B revenue bar is a meaningful step up, and if management raises full-year guidance, this could be the catalyst that breaks the semiconductor sector out of its consolidation range. Watch specifically for data center/AI revenue commentary — ADI’s converters and interface chips are increasingly being designed into AI accelerator platforms. Fabrinet’s Monday print will also set directional context here. This is a high-conviction swing trade entry on any constructive pre-market reaction.

TGT — Target Corporation | Reports: Wednesday, August 19 (Before Open) Consensus: EPS $2.21, Revenue $26.0B Action: SHORT bias (or sideline) — Target has structural headwinds; a beat needs to be significant to overcome the narrative. Claude’s take: Target shares the top anticipation score of the week’s Wednesday slate (11), but unlike ADI, the setup is bearish-leaning. Target has been losing discretionary market share to Walmart and Amazon for over two years, and its merchandise mix (heavy in apparel, home goods, and electronics) makes it particularly vulnerable when consumers trade down. The $2.21 EPS / $26B revenue consensus already embeds conservative expectations — but “low bar” trades only work if traffic trends and gross margins are actually improving. Watch same-store sales growth and inventory levels closely: if inventory is still bloated or shrink/theft commentary returns, the stock goes lower regardless of the EPS print. The HD/LOW read-through from Tuesday and Wednesday will also matter — if those home improvement names suggest consumer wallet stress, TGT’s discretionary categories face the same headwind. I’d lean short the gap-up if TGT opens higher on merely in-line results.

LOW — Lowe’s Companies, Inc. | Reports: Wednesday, August 19 (Before Open) Consensus: EPS $4.25, Revenue $26.18B Action: BUY (conditional on HD beat Tuesday) — Lowe’s is the logical follow-through trade to Home Depot. Claude’s take: Lowe’s is the direct read-through from Home Depot’s Tuesday report — if HD beats and raises guidance, LOW pre-market Wednesday will already be pricing in optimism. The $4.25 EPS / $26.18B revenue bar is essentially symmetrical to HD’s in terms of expectations calibration. The key Lowe’s-specific angle is its Pro customer strategy — Lowe’s has been aggressively expanding Pro sales to compete with HD’s traditionally stronger contractor business. If that initiative is showing traction, margins should be improving. The risk: Lowe’s has historically underperformed HD in housing downturns, and any evidence that the recovery is HD-specific rather than sector-wide would punish LOW. Trade LOW off HD’s reaction, not independently.

TJX — The TJX Companies, Inc. | Reports: Wednesday, August 19 (Before Open) Consensus: EPS $1.18, Revenue $15.13B Action: BUY — Off-price retail is a structural winner in the current consumer environment; this is one of the cleanest long setups of the week. Claude’s take: TJX (Marshalls, TJ Maxx, HomeGoods, Winners) is perhaps the single best-positioned retailer in the current environment — as consumers trade down from full-price department stores and premium brands, off-price channels absorb that spending. The $1.18 EPS on $15.13B revenue is a solid bar, and TJX has beaten consistently for multiple consecutive quarters. Inventory availability (the “treasure hunt” model depends on vendor excess, which is plentiful in a soft goods environment) and traffic comps are the numbers to watch. This is not a high-drama setup — it’s a steady compounder with low downside risk on the print. An in-line result is a hold; a beat is a meaningful gap-up candidate. This is the safest long-earnings trade of the week for risk-conscious swing traders.

DY — Dycom Industries, Inc. | Reports: Wednesday, August 19 (Before Open) Consensus: EPS $4.36, Revenue $1.97B Action: BUY — Telecom infrastructure buildout beneficiary with a direct BEAD program and fiber deployment tailwind. Claude’s take: Dycom is a specialty contractor providing construction, maintenance, and engineering services to telecom companies — it is one of the purest plays on the US fiber and broadband infrastructure buildout, including BEAD (Broadband Equity, Access, and Deployment) federal funding that has been accelerating in 2025-2026. The $4.36 EPS / $1.97B revenue estimate is ambitious but achievable if telecom customer spending has held up — AT&T, Verizon, and Lumen have all been indicating continued fiber capex. This is an under-the-radar earnings setup with real upside: low retail anticipation (score 3) combined with strong secular tailwinds is classic “nobody’s watching, but they should be” territory. Strong results here are also a positive signal for tower companies and other telecom infrastructure names.

EL — The Estée Lauder Companies Inc. | Reports: Wednesday, August 19 (Before Open) Consensus: EPS $0.31, Revenue $3.55B Action: SHORT bias — Estée Lauder remains structurally challenged by China exposure and prestige beauty normalization. Claude’s take: Estée Lauder’s $0.31 EPS on $3.55B revenue reflects a company still in restructuring mode following one of the most painful multi-year earnings revisions in large-cap consumer staples history. The core problem: EL over-indexed to China travel retail (Hainan duty-free), which collapsed, and its prestige beauty pricing power is being challenged by indie brands and the Sephora effect. The restructuring plan (Project NEXUS) has been positive for cost discipline, but top-line growth remains elusive as the Chinese consumer continues to disappoint. Even a beat here will be scrutinized for quality — are organic sales actually growing, or is this a cost-cut story? I’d fade any significant gap-up; the structural issues aren’t resolved in one quarter.

ZIM — ZIM Integrated Shipping Services Ltd. | Reports: Wednesday, August 19 (Before Open) Consensus: EPS -$0.10, Revenue $1.63B Action: AVOID (or speculative long if freight rates have spiked) — Container shipping is a rate-driven, cyclical business; earnings are backward-looking. Claude’s take: ZIM is an Israeli container shipping company whose fortunes are almost entirely determined by spot and contract freight rates. The -$0.10 EPS consensus on $1.63B revenue reflects the continued normalization of freight rates from the extreme post-COVID highs, but the real-time data from Drewry, Freightos, and the Shanghai Containerized Freight Index (SCFI) is what actually moves ZIM’s stock — not the backward-looking quarterly print. If freight rates have trended higher recently (which can happen quickly due to geopolitical disruptions like Red Sea rerouting), ZIM could surprise to the upside and declare a dividend. But trying to trade the earnings print specifically on a shipping company is a low-edge exercise — the data is publicly available before the report.

BILL — BILL Holdings, Inc. | Reports: Wednesday, August 19 (After Close) Consensus: EPS $0.25, Revenue $0.43B Action: BUY (if SMB spending data has been constructive) — SMB fintech with a beaten-down valuation and potential for a re-rating if churn stabilizes. Claude’s take: BILL Holdings provides cloud-based financial operations software to small and mid-sized businesses — a segment that has faced real headwinds as SMB formation slowed and interest rates squeezed small business cash flows. The stock has been significantly de-rated from its pandemic highs, which means the bar for a positive reaction is actually lower than it used to be. At $0.25 EPS / $0.43B, the expectations are modest. The key metric to watch is net revenue retention (NRR) and total payment volume (TPV) — if SMBs are processing more payments through BILL, that’s a sign of ecosystem stickiness despite the challenging environment. An after-close print gives Wednesday traders time to set up; if the numbers are good, the Thursday morning gap could be significant. This is a moderate-conviction long setup.

📅 Thursday, August 20

WMT — Walmart Inc. | Reports: Thursday, August 20 (Before Open) Consensus: EPS $0.73, Revenue $186.32B Action: BUY (highest-conviction call of the week) — Walmart is the ultimate “trade-down” beneficiary and a market-moving macro proxy; this print matters for the entire market. Claude’s take: With an anticipation score of 21 — by far the highest of the week — Walmart’s report is the single most important event of this entire week and arguably the most important retail earnings report of Q2 2026. At $186.32B in revenue, Walmart is essentially reporting on the US consumer economy. The key metrics: grocery same-store comps (Walmart has been gaining share from Whole Foods, Kroger, and traditional grocers), advertising revenue (Walmart Connect is becoming a meaningful high-margin business), international segment (Flipkart/India and Walmex Mexico), and e-commerce penetration. The trade-down consumer thesis has been Walmart’s engine — even middle- and upper-income shoppers have been shifting grocery spend to Walmart. If management reaffirms or raises full-year guidance, expect a broad market lift that morning. A miss here — especially on US comparable store sales — would be a genuine macro warning signal. I would be long WMT into the print with conviction; the risk/reward skews long given the company’s demonstrated execution over the last eight consecutive quarters.

BABA — Alibaba Group Holding Limited | Reports: Thursday, August 20 (Before Open) Consensus: EPS $1.77, Revenue $38.63B Action: BUY (with China macro hedge) — Alibaba trades at a compelling discount to global internet peers; any AI cloud upside is a re-rating catalyst. Claude’s take: Alibaba at $38.63B revenue consensus is trading at what many EM-focused analysts consider a structural discount to fair value, largely due to China regulatory risk and geopolitical ADR uncertainty. The real 2026 story for BABA is Alibaba Cloud and its integration of AI services — if cloud revenue reaccelerates (driven by enterprise AI adoption on Qwen and Tongyi), the market will begin to price Alibaba much more like a cloud company and less like a Chinese regulatory risk basket. The $1.77 EPS bar is achievable, and with the BABA share buyback program still active, EPS support is structural. The anticipation score of 12 reflects broad retail and institutional interest — this is a high-volume, high-liquidity trade with a real catalyst. Pair this with the BIDU Monday read-through for a broader China AI theme assessment.

HIVE — HIVE Digital Technologies Ltd. | Reports: Thursday, August 20 (After Close) Consensus: EPS -$0.20, Revenue $0.08B Action: AVOID (unless crypto prices have spiked this week) — Crypto mining equities are pure leveraged Bitcoin proxies; earnings are secondary to BTC price. Claude’s take: HIVE Digital is a cryptocurrency miner that has pivoted toward GPU-based AI compute alongside traditional Bitcoin mining — a narrative that’s attractive in theory but hard to monetize quickly. The -$0.20 EPS on $0.08B revenue reflects the capital-intensive, low-margin reality of the mining business. The anticipation score of 6 reflects retail’s enduring love for crypto-adjacent names, but swing trading a miner around earnings makes little sense when the stock moves 5-10% daily based on Bitcoin price action. If you’re bullish crypto, trade BTC or MSTR directly. Wait on HIVE.

ROST — Ross Stores Inc. | Reports: Thursday, August 20 (After Close) Consensus: EPS $1.92, Revenue $6.12B Action: BUY — Ross is TJX’s close cousin and should catch the same off-price retail tailwind; a clean setup. Claude’s take: Ross Stores is the off-price retail companion trade to TJX Companies (Wednesday). If TJX reports strong comps on Wednesday morning, ROST will likely gap up Thursday on sympathetic buying, and then confirm its own thesis after close. The $1.92 EPS / $6.12B revenue bar is reasonable for a company that has been consistently executing. The difference from TJX: Ross has heavier exposure to lower-income consumers and value-focused markets, which in the current environment is actually a competitive advantage — there is no shortage of deal-seeking shoppers. Watch merchandise margin and inventory levels; if those metrics are clean, this is a high-probability beat. A good setup for swing traders looking for sector rotation out of TGT weakness into off-price strength.

AAP — Advance Auto Parts Inc. | Reports: Thursday, August 20 (Before Open) Consensus: EPS $0.81, Revenue $2.03B Action: AVOID (or speculative long for turnaround believers) — AAP is a deep-in-restructuring name with significant execution risk. Claude’s take: Advance Auto Parts has been one of the worst-performing large-cap retailers over the past several years — massive restructuring, store closures, executive turnover, and persistent underperformance vs. O’Reilly and AutoZone have demolished shareholder value. The $0.81 EPS on $2.03B revenue represents a still-challenged business trying to stabilize. The auto parts sector itself is favorable (aging vehicle fleet, DIY demand strong), but AAP keeps fumbling execution while competitors gain share. Unless there’s concrete evidence of same-store sales stabilization and margin recovery in the print, I’d use any rally here to get short. The turnaround thesis has disappointed too many times to trust blindly.

CAMP — CAMP4 Therapeutics Corporation | Reports: Thursday, August 20 (After Close) Consensus: EPS -$0.23, Revenue ~$0 Action: AVOID — Pre-revenue RNA therapeutics company; this is a pipeline watch, not an earnings trade. Claude’s take: CAMP4 is developing RNA regulatory therapeutics for rare genetic diseases — a scientifically interesting but deeply pre-commercial stage company. The -$0.23 EPS on zero revenue is exactly what you’d expect, and the anticipation score of 4 is surprisingly elevated for a company at this stage, possibly reflecting pipeline milestone speculation. Swing traders have no edge here without deep clinical knowledge. Avoid the earnings trade entirely.

NU — Nu Holdings Ltd. | Reports: Thursday, August 20 (After Close) Consensus: EPS $0.20, Revenue $5.45B Action: BUY — Latin American digital banking darling with one of the best growth profiles in global fintech. Claude’s take: Nu Holdings (Nubank) is one of the most compelling fintech growth stories globally — with over 100 million customers primarily in Brazil, Mexico, and Colombia, it is the world’s largest digital bank by customer count outside of Asia. The $5.45B revenue estimate with $0.20 EPS reflects a company rapidly scaling revenue while managing credit risk in EM markets. The key metrics: active customer growth (especially Mexico expansion), average revenue per active customer (ARPAC), and non-performing loan (NPL) trends in Brazil. If Brazil’s macro environment hasn’t deteriorated significantly, Nu should deliver a strong print. The anticipation score of 4 undervalues the institutional interest — this is a high-quality growth name that deserves more attention this week. Strong results will drive a meaningful gap-up, particularly given the broader fintech tailwind from KLAR’s Tuesday print.

ATHM — Autohome Inc. | Reports: Thursday, August 20 (Before Open) Consensus: EPS $0.24, Revenue $0.19B Action: AVOID — Niche Chinese auto-advertising platform with limited US swing-trading relevance. Claude’s take: Autohome is China’s leading online automobile marketplace — essentially the Cars.com of China. The $0.19B revenue / $0.24 EPS estimates are modest, and the anticipation score of 3 doesn’t justify a dedicated swing setup. Chinese auto sales data has been mixed in 2026 given EV price wars and macro uncertainty, which creates risk around ad spend from auto OEMs. The BIDU print Monday will give a broader sense of China digital advertising health — if BIDU’s ad revenue disappoints, ATHM’s setup deteriorates. This is a pass for US swing traders.

📅 Friday, August 21

BJ — BJ’s Wholesale Club Holdings, Inc. | Reports: Friday, August 21 (Before Open) Consensus: EPS $1.15, Revenue $5.89B Action: BUY — Warehouse club model benefits from the same trade-down thesis as Walmart and Costco; a solid end-of-week setup. Claude’s take: BJ’s is the Northeast-focused warehouse club operator — smaller than Costco and Sam’s Club (Walmart), but operating in the same structural sweet spot of trade-down consumer spending and membership-driven recurring revenue. The $1.15 EPS / $5.89B revenue bar should be achievable if the WMT/TJX/ROST prints earlier in the week confirm that value-oriented retail is working. The anticipation score of 5 is respectable for a Friday print. BJ’s has been investing in private label expansion and digital/pickup capabilities — if those investments are showing returns, margin expansion is a positive catalyst. The Friday timing is tricky for swing trades (weekend gap risk), but a strong WMT Thursday print should pre-position the trade favorably by Friday morning.

SLGL — Sol-Gel Technologies Ltd. | Reports: Friday, August 21 (Before Open) Consensus: EPS -$2.31, Revenue ~$0 Action: AVOID — Israeli specialty pharma with no commercial revenue; a deep-loss print with minimal relevance for swing traders. Claude’s take: Sol-Gel is a specialty pharmaceutical company focused on dermatology — it has had one approved product (Twyneo) and is navigating the commercial launch phase. A -$2.31 EPS loss on essentially zero revenue tells you the commercial ramp is not yet meaningful. Anticipation score of 1 confirms almost no one is watching. Skip.

UI — Ubiquiti Inc. | Reports: Friday, August 21 (Before Open) Consensus: EPS $3.67, Revenue $0.83B Action: BUY (quiet conviction setup) — Ubiquiti is a consistently profitable, founder-led networking hardware company that often surprises to the upside with minimal fanfare. Claude’s take: Ubiquiti is one of the most interesting under-the-radar earnings setups of the week — a networking hardware company (UniFi, EdgeMax, airMax product lines) that has carved out a dominant niche among enterprise, prosumer, and ISP customers with high-margin, direct-sales model products. The $3.67 EPS / $0.83B revenue estimate is meaningful, and Ubiquiti has a track record of underpromising and overdelivering. The anticipation score of 1 is actually a feature, not a bug — low expectations, consistent execution, founder-controlled capital allocation. In the broader AI networking infrastructure tailwind (where FN and ADI also benefit), Ubiquiti’s WiFi 7 and fiber product lines are seeing real enterprise upgrade cycles. This is one of those quiet Friday prints that can generate a nice 5-10% gap-up with no fanfare. Watch this one carefully.

AMTY, BKE, BUFF, BVNRY, DCOY — Amerityre Corp., Buckle Inc., Blue Buffalo Pet Products, Bavarian Nordic, Decoy Therapeutics | Reports: Friday, August 21 (Before Open) Consensus: No estimates available (anticipation score: 0) Action: AVOID — No credible estimates, minimal analyst coverage, zero actionable swing setups. Claude’s take: These names represent the tail end of the earnings calendar with anticipation scores of zero and no available EPS/revenue estimates. Amerityre is a micro-cap specialty tire manufacturer; Buckle is a specialty apparel retailer; Blue Buffalo (now part of General Mills, oddly listed separately) is a pet food brand; Bavarian Nordic is a Danish vaccine maker; and Decoy Therapeutics is a pre-revenue biotech. None of these represent actionable swing trades around the earnings event. Swing traders should have no positions in these names heading into Friday’s session on an earnings basis.

Economic Calendar

⚠️ Important context: All the economic events listed fall in the prior week of August 12–14 — they will have already printed before our August 17–21 trading week begins. However, those prints will set the macro backdrop and market tone for the entire earnings-heavy week ahead, so understanding their implications is essential.

Core CPI m/m — Wednesday, August 12 | 8:30 AM ET Forecast: 0.2% | Previous: 0.0% Market impact: A 0.2% monthly core CPI print represents a modest step-up from flat, but remains consistent with the disinflation trajectory targeting ~2.5% y/y. If the print comes in at 0.2% or below, equities should open the following week constructively — particularly rate-sensitive growth stocks (tech, homebuilders, REITs). A hot print above 0.3% would reignite Fed hawkishness fears, weighing on the sector rotation theme and potentially compressing the multiple expansion implied in ADI, FN, and BILL’s setups.

Core CPI y/y — Wednesday, August 12 | 8:30 AM ET Forecast: 2.5% | Previous: 2.6% Market impact: A continuation of the y/y deceleration (2.6% → 2.5%) is incrementally bullish for Fed rate cut expectations — this is the number the Fed watches most closely and the one that matters most for duration-sensitive assets. If core CPI y/y prints at or below 2.5%, the market enters the August 17 week with a “soft landing” narrative intact, boosting consumer discretionary and retail names like WMT, HD, and TGT. A miss above 2.7% would be the single biggest macro headwind for the week’s earnings slate.

CPI m/m — Wednesday, August 12 | 8:30 AM ET Forecast: 0.1% | Previous: -0.4% Market impact: The rebound from -0.4% to +0.1% expected reflects base effect normalization after energy-driven deflation — this is not alarming. If headline CPI m/m comes in above 0.2%, energy/commodity price re-acceleration becomes a narrative risk, particularly for transportation and logistics companies (ZIM). A soft print maintains the low-inflation environment that supports consumer spending, which is the essential thesis behind WMT and TJX’s bullish setups this week.

CPI y/y — Wednesday, August 12 | 8:30 AM ET Forecast: 3.4% | Previous: 3.5% Market impact: The slow grind lower in headline CPI y/y is constructive but not exciting — at 3.4%, inflation remains above the Fed’s 2% target. The key market-moving scenario is a surprise below 3.2%, which would dramatically accelerate Fed cut pricing and unleash a risk-on rally into options expiration week. Conversely, a print above 3.6% reopens the “higher for longer” debate and would disproportionately hurt the consumer retail names (HD, LOW, TGT) reporting later in the week as it implies continued consumer budget pressure.

Core PPI m/m — Thursday, August 13 | 8:30 AM ET Forecast: 0.3% | Previous: 0.2% Market impact: Producer prices are a leading indicator for future consumer prices — a 0.3% core PPI acceleration is the hotter of this week’s inflation readings, and the market will parse this carefully for evidence that the disinflation trend is losing momentum. For swing traders, a hot PPI print would be negative for margin-sensitive retailers (Target, Lowe’s) heading into their Wednesday/Thursday reports, as input cost pressures could begin flowing through to gross margins in H2 2026.

PPI m/m — Thursday, August 13 | 8:30 AM ET Forecast: 0.2% | Previous: -0.3% Market impact: Like headline CPI, the PPI rebound from -0.3% to +0.2% reflects normalization from the prior month’s energy-driven deflation. A print at or below 0.2% is neutral-to-bullish; a significant upside surprise (+0.4% or higher) would be the real red flag that input cost deflation is ending, which would weigh on retailer gross margin guidance for Q3. This number directly informs how much “cover” Walmart and Target have on pricing power commentary during their calls.

Unemployment Claims — Thursday, August 13 | 8:30 AM ET Forecast: 202K | Previous: 199K Market impact: Claims ticking up from 199K to 202K is normal seasonal noise and not a recession signal at these levels — the market generally looks through sub-210K prints as “labor market is fine.” If claims spike above 225K, that would begin to raise recession concerns that would cast a shadow over the consumer spending thesis underpinning WMT, HD, and TGT. Conversely, a surprise drop below 195K confirms labor market resilience and is incrementally bullish for all the consumer/retail names reporting this week.

Core Retail Sales m/m — Friday, August 14 | 8:30 AM ET Forecast: 0.2% | Previous: -0.2% Market impact: A bounce from -0.2% to +0.2% in core retail sales (ex-autos) would confirm that the July consumer spending pullback was a one-month anomaly rather than a trend break — this is a critically important setup data point for every retail earnings report this week. If core retail sales come in at +0.3% or better, swing traders should enter the week with higher confidence in the HD/WMT/TJX long setups. A second consecutive negative print would be a serious warning sign for discretionary retail and could justify a more defensive posture heading into the earnings gauntlet.

Retail Sales m/m — Friday, August 14 | 8:30 AM ET Forecast: 0.1% | Previous: 0.2% Market impact: A slight deceleration in headline retail sales from 0.2% to 0.1% is benign — this is consistent with a consumer that’s spending carefully but not retrenching. The directional read-through for swing traders: positive retail sales data entering the week is the single most important macro “permission slip” for going long the consumer retail names (WMT, HD, LOW, TJX, ROST, BJ). If this number disappoints, the earnings bar suddenly feels higher and the margin for error narrows.

Prelim UoM Consumer Sentiment — Friday, August 14 | 10:00 AM ET Forecast: 54.4 | Previous: 54.4 Market impact: A flat consumer sentiment reading at 54.4 is historically low — levels below 60 have historically correlated with elevated recession anxiety — but the market has largely learned to live with persistently subdued UoM readings as tariff and political uncertainty keep the survey depressed even when actual spending is holding up. An unexpected drop below 50 would be market-negative and particularly damaging for discretionary retail into earnings week. A surprise rebound above 58 would be meaningfully bullish for consumer-facing stocks.

Prelim UoM Inflation Expectations — Friday, August 14 | 10:00 AM ET Forecast: N/A | Previous: 4.2% Market impact: The 4.2% prior reading represents uncomfortably elevated long-term inflation expectations relative to the Fed’s 2% target — this is the metric that genuinely worries the Fed, as de-anchored expectations can become self-fulfilling. If this print remains elevated above 4.0%, it keeps Fed rate cut expectations anchored cautiously, which acts as a modest headwind for high-multiple growth stocks (ADI, BILL) even if the actual CPI data is improving. A decline below 3.8% would be a meaningful dovish signal and give a green light to rate-sensitive equity longs.

IPO Watch

The most recently priced IPOs from the list span late April through late May 2026 — now approximately 3 months post-IPO, meaning several are in or approaching the end of their initial lock-up period.

CBRS — Cerebras Systems Inc. | $5.55B offering Claude’s take: Cerebras is the most significant IPO on the recent list by a wide margin — a next-generation AI chip company that went public at $185/share, directly challenging NVIDIA with its wafer-scale engine (WSE) architecture optimized for AI inference. At $5.55B in offering size, institutional demand was presumably robust, but the real question three months post-IPO is whether the hyperscaler customer concentration risk (Cerebras has historically been heavily dependent on a small number of large customers) has diversified. If CBRS is trading above its $185 IPO price, it has momentum; if it’s below, the secondary buyers remain underwater and the stock remains technically fragile. Day-1 buyers at $185 should be evaluating a trailing stop now — the lock-up window (typically 180 days from IPO) is approaching, and insider selling pressure will intensify in November 2026. New buyers: wait for the lock-up expiry flush and then reassess.

BXDC — Blackstone Digital Infrastructure Trust Inc. | $1.75B offering Claude’s take: Blackstone’s Digital Infrastructure Trust is an institutional-grade data center and digital infrastructure REIT-like vehicle that went public at $20/share. This is not a retail meme stock — it’s a yield-oriented, income-focused structure for investors wanting AI data center exposure with a dividend component. At $1.75B, this was a large, professionally placed offering with minimal retail participation on day 1. The relevant question for swing traders is whether rising AI capex demand has pushed data center valuations higher since the May 2026 offering — if BXDC is trading at a premium to $20, it has found its institutional support level and can be held for income. Not a swing trade target, but worth monitoring as a macro confirmation of AI infrastructure demand alongside FN and ADI’s earnings.

FRVO — Fervo Energy Co. | $1.89B offering Claude’s take: Fervo Energy is a next-generation geothermal power company that went public at $27/share — one of the most interesting clean energy IPOs of 2026. Fervo uses horizontal drilling technology (borrowed from oil & gas) to unlock enhanced geothermal systems, producing 24/7 carbon-free baseload power — which is exactly what AI data centers need. The $1.89B offering was aggressively priced on the AI energy demand narrative, and the stock’s performance since May will tell you whether institutional buyers absorbed the offering cleanly. If FRVO has held above $27, it’s a legitimate swing long on any pullback toward the IPO price; data center power supply is genuinely scarce and geothermal is differentiated from intermittent renewables. Retail participation on day 1 at the IPO price was justified given the unique business model; swing traders should now look for a clean technical entry rather than chasing.

LCLN — Lincoln International, Inc. | $421M offering Claude’s take: Lincoln International is a leading middle-market investment bank (M&A advisory) that went public at $20/share. This is a classic financial services IPO that benefits from M&A activity cycles — and 2026 has seen a meaningful pickup in middle-market deal flow as rate anxiety has moderated. The $421M offering is modest for a firm of Lincoln’s reputation, suggesting management was conservative on valuation. Three months in, the stock should have established a clear trading range. If M&A activity data for Q2 2026 is constructive, Lincoln is a legitimate buy on any pullback toward $20. Comparable comps: Houlihan Lokey (HLI) and Lazard (LAZ). At the right price, this is a quality franchise at a reasonable multiple — but swing traders should wait for the first earnings report (likely August or September) to get real public financial data before sizing up.

SPCX — Space Exploration Technologies Corp (SpaceX) | ~$75B filing Claude’s take: The SpaceX filing is the elephant in the room for the entire IPO market — a $75B sought value filing that would represent one of the largest IPOs in US history. However, this is filed, not priced — meaning retail access remains zero at this stage, and the actual IPO timing, structure (full IPO vs. direct listing vs. partial float), and final valuation are all unknown. What matters for swing traders right now is the signal effect: a SpaceX filing validates the private-to-public pipeline for frontier technology and could boost sentiment across defense, space, and launch-adjacent public equities (RKLB, ASTS, LUNR). Do not front-run the SpaceX IPO itself — it will be oversubscribed at the institutional level and retail will receive minimal allocation. Watch for sympathy moves in the space sector instead.

ODTX — Odyssey Therapeutics, Inc. | $279M offering Claude’s take: Odyssey Therapeutics is a precision medicine company focused on autoimmune diseases that priced at $18/share in May 2026. The $279M offering gave it a solid cash runway, and the autoimmune space (IgAN, lupus, IBD) has been one of the hottest biotech subsectors in 2025-2026 following several successful clinical readouts. If ODTX has held above $18, the institutional book is solid and the stock merits monitoring for a clinical catalyst trade. However, retail should not chase it above $25 on no new data — the early IPO premium fade is real in biotech. Wait for either a meaningful pullback to the $18-20 range or a concrete data readout.

Week Ahead Summary

🔴 Biggest Risk: The macro backdrop entering the week is everything — if the August 12–14 data (CPI, PPI, Retail Sales) printed hotter than expected, the Fed-cut narrative gets pushed out and all the consumer retail longs (WMT, HD, TJX, ROST) face multiple compression heading into their earnings prints. A hot CPI y/y print above 3.6% or a disappointing retail sales number (-0.2% or worse) would be the single most dangerous backdrop for this week’s earnings-heavy agenda.
🟢 Biggest Opportunity: Wednesday morning is the most action-packed session of the week — ADI, TGT, LOW, and TJX all report before open simultaneously. A clean ADI beat-and-raise would signal the semiconductor/AI infrastructure demand cycle is truly re-accelerating, while a TJX beat would confirm the off-price consumer trade is working. If both land well, Wednesday morning opens with a powerful risk-on signal. Follow-through into WMT Thursday would make this one of the most bullish retail earnings weeks of 2026.
📊 Key Technical Levels: SPY — watch the 50-day MA as the critical support level; if it holds through WMT Thursday, the path to all-time highs reopens. QQQ — ADI’s Wednesday print is the semiconductor sector’s credibility test; a strong reaction should push QQQ above its recent consolidation range. IWM (small caps) — BILL, FLXS, and DY are the small-cap reads; strong results there would finally give small-cap value a catalyst to play catch-up.
📐 Sector Positioning: Overweight consumer staples/value retail (WMT, TJX, ROST, BJ’s) — the trade-down consumer thesis is your highest-probability sector theme this week. Overweight AI infrastructure (FN, ADI) — if Fabrinet’s optical networking demand is robust Monday night, set up ADI long Wednesday pre-market. Underweight discretionary full-price retail (TGT, EL, AAP) — these names face the highest execution risk and most skeptical market positioning.
⚖️ Overall Positioning: RISK-ON, but tiered. Enter the week with a constructive bias assuming the prior-week macro data was not alarming. The earnings calendar is dominated by quality operators (WMT, TJX, ADI, FN, NU) with defensible business models and achievable consensus estimates. Size your highest-conviction longs (WMT, TJX, ADI, UI) at full position; keep speculative biotech and crypto-adjacent names (GOSS, FDMT, HIVE) at zero. The biggest mistake this week would be getting distracted by low-score noise (NRXP, PRE, GORO) and missing the institutional-grade setups hiding in plain sight.

This report is for informational and educational purposes only and does not constitute personalized investment advice. Past earnings patterns and sector correlations do not guarantee future results. All estimates and forecasts are as of report date and subject to change.